Moderna Vaccine Is Better Than Pfizer-BioNTech at Tackling Delta Variant, US Study Found The Pfizer-BioNTech vaccine's efficacy has dropped to 42 percent from 76 percent since the Delta variant took hold. By Sissi Cao
Safeguarding Cultural Heritage Through the Largest Art and Collectibles Transfer in History By Maeve Zimmerman
